Discovery of O-GlcNAc transferase inhibitors
- J Am Chem Soc. 2005 Oct 26;127(42):14588-9. doi: 10.1021/ja0555217.
- 1. Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
O-GlcNAcylation of serine and threonine residues is a dynamic and essential post-translational modification involved in signaling pathways in eukaryotes. Studies of O-GlcNAcylation would be aided by small-molecule inhibitors of O-GlcNAc transferase (OGT), the sole enzyme know to mediate this modification, but discovery of such molecules has been hampered by poor expression of cloned OGT and lack of suitable high-throughput screens. This Communication describes the development an expression system to access large amounts of the catalytic domain of OGT and the implementation of a fluorescence-based substrate analogue displacement assay that has led to the discovery of a set of OGT inhibitors. This work lays the foundation for both structural and functional analysis of the catalytic domain of OGT.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Metabolic Disease
-
target: OGTResearch Areas: Metabolic Disease